-
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
(PA-20-166)
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of General Medical Sciences
National Cancer Institute
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Library of Medicine
National Institute of Mental Health
National Institute of Nursing Research
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
John E. Fogarty International Center
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
National Institute on Minority Health and Health Disparities
National Center for Advancing Translational Sciences
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): Due dates vary by awarding IC
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Independent Scientist Award (Parent K02 - Independent Clinical Trial Required)
(PA-20-171)
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Standard dates apply.
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional)
(PA-20-172)
National Institute on Minority Health and Health Disparities
National Institute on Aging
National Cancer Institute
National Institute on Drug Abuse
Application Receipt Date(s): Standard dates apply.
The first standard due date for this FOA is October 5, 2020.
-
Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required)
(PA-20-173)
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Standard dates apply.
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed)
(PA-20-174)
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Standard dates apply.
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
IDeA Program Infrastructure for Clinical and Translational Research (IDeA-CTR)(U54 - Clinical Trial Optional)
(PAR-20-175)
National Institute of General Medical Sciences
Application Receipt Date(s): October 7, 2020; October 7, 2021, and October 7, 2022
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Mucosal Immunology Studies Team (MIST) (U01 Clinical Trial Not Allowed).
(RFA-AI-20-027)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): October 9, 2020
-
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
(RFA-RM-20-019)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): July 15, 2020.
No late applications will be accepted for this Funding Opportunity Announcement.